Potassium-competitive acid blocker vs proton-pump inhibitor in patients receiving antithrombotic therapy who are at high risk for gastrointestinal bleeding: Rationale and design of the randomized PROTECT- HBR trial.
Hwan-Cheol Park, Young Jin Choi, Myeong-Ho Yoon, Kyoung-Ha Park, Jung-Won Suh, Wang Soo Lee, Eue-Keun Choi, Young-Hyo Lim, Eun-Sun Jin, Tae-Hyun Yang, Jin-Ok Jeong, Se Hun Kang, Eun-Seok Shin, Sung-Ho Her, Soon Jun Hong, Weon Kim, Chang-Wook Nam, Do-Yoon Kang, Jung-Min Ahn, Junghoon Lee, Seung-Jung Park, Duk-Woo Park, Sang Min Kim, Byeong-Keuk Kim, Sang-Hyun Kim, Jong-Young Lee, Jinho Lee, Han-Su Park, Kee Don Choi, Sung Uk Kwon, Hanbit Park, Yong-Hoon Yoon
American heart journal 2025;287():50-60